CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)	Total	Cumulative Effect, Period of Adoption, Adjustment	Common stock	Additional paid-in capital	Retained earnings	Retained earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated other comprehensive income (loss)	Treasury stock	Noncontrolling interest in consolidated subsidiaries
Beginning balance at Dec. 29, 2018	$ 1,175,738,000		$ 27,900,000	$ 0	$ 2,067,811,000		$ (303,185,000)	$ (692,549,000)	$ 75,761,000
Beginning balance (Accounting Standards Update 2016-16) at Dec. 29, 2018		$ (8,886,000)				$ (8,886,000)
Increase (Decrease) in Shareholders' Equity
Net earnings	152,105,000				146,408,000				5,697,000
Other comprehensive income (loss)	(10,429,000)						(10,237,000)		(192,000)
Cash dividends declared	(32,503,000)				(32,503,000)
Dividends to noncontrolling interests	(7,737,000)								(7,737,000)
Purchase of noncontrolling interest	(27,845,000)			(277,000)					(28,122,000)
Purchase of treasury shares	(62,915,000)							(62,915,000)
Stock plan exercises	(12,989,000)							(12,989,000)
Stock options exercised	(13,619,000)			3,756,000	(972,000)			(16,403,000)
Stock option expense	2,772,000			2,772,000
Stock awards	8,815,000			707,000				8,108,000
Ending balance at Dec. 28, 2019	1,189,745,000		27,900,000	0	2,173,802,000		(313,422,000)	(743,942,000)	45,407,000
Increase (Decrease) in Shareholders' Equity
Net earnings	142,149,000				140,693,000				1,456,000
Other comprehensive income (loss)	5,608,000						3,636,000		1,972,000
Cash dividends declared	(38,393,000)				(38,393,000)
Dividends to noncontrolling interests	(5,642,000)								(5,642,000)
Purchase of noncontrolling interest	(53,611,000)				(31,067,000)				(22,544,000)
Purchase of treasury shares	(56,491,000)							(56,491,000)
Stock plan exercises	(14,489,000)							(14,489,000)
Stock options exercised	(18,961,000)			6,335,000				(25,296,000)
Stock option expense	2,628,000			2,628,000
Stock awards	12,246,000			4,042,000				8,204,000
Ending balance at Dec. 26, 2020	1,207,836,000		27,900,000	335,000	2,245,035,000		(309,786,000)	(781,422,000)	25,774,000
Increase (Decrease) in Shareholders' Equity
Net earnings	197,725,000				195,630,000				2,095,000
Other comprehensive income (loss)	45,540,000						46,659,000		(1,119,000)
Cash dividends declared	(42,472,000)				(42,472,000)
Purchase of treasury shares	(26,100,000)							(26,100,000)
Stock plan exercises	(21,547,000)							(21,547,000)
Stock options exercised	(23,895,000)			15,357,000	(3,886,000)			(43,138,000)
Stock option expense	2,538,000			2,538,000
Stock awards	26,182,000			13,963,000				12,219,000
Ending balance at Dec. 25, 2021	$ 1,413,597,000		$ 27,900,000	$ 1,479,000	$ 2,394,307,000		$ (263,127,000)	$ (773,712,000)	$ 26,750,000